wegovy reimbursement
56% Of PCPs See Wegovy Refusal-Boost Obesity Treatment Coverage
56% of primary care physicians report that insurance companies deny Wegovy prescriptions, leaving many patients without access. Insurance refusals stem from legacy BMI thresholds and incomplete comorbidity documentation, but a focused reimbursement strategy can increase approvals by up to 37%. Medical Disclaimer: This article is for informational purposes only and